OSIR - Osiris Therapeutics, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue142,824118,514109,37479,707
Cost of Revenue38,13932,68130,73327,020
Gross Profit104,68585,83378,64152,687
Operating Expenses
Research Development6,7644,1386,3244,867
Selling General and Administrative87,16883,68476,41366,125
Non Recurring----
Others----
Total Operating Expenses132,071120,503113,47098,012
Operating Income or Loss10,753-1,989-4,096-18,305
Income from Continuing Operations
Total Other Income/Expenses Net-225-645417-16,905
Earnings Before Interest and Taxes10,753-1,989-4,096-18,305
Interest Expense----
Income Before Tax10,528-2,634-3,679-35,210
Income Tax Expense-26,005-1,39870544
Minority Interest----
Net Income From Continuing Ops36,533-1,236-3,749-35,754
Non-recurring Events
Discontinued Operations36810,02110,02110,021
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income36,9018,785-3,749-35,754
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares36,9018,785-3,749-35,754